CompletedN/Aketamine

Effect of Esketamine on Anxiety State in Patients Undergoing Abdominal Tumor Surgery

Sponsored by Zhejiang Cancer Hospital

NCT ID
NCT06530706
Target Enrollment
185 participants
Start Date
2024-08-05
Est. Completion
2025-06-30

About This Study

To evaluate whether esketamine can relieve anxiety in patients undergoing abdominal tumor surgery.

Conditions Studied

Anxiety StateEsketamine

Interventions

  • Esketamine
  • normal saline

Eligibility

Age:18 Years - 70 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Patients undergoing abdominal tumor surgery;
* older than 18 years old and younger than 70 years old;
* ASA grade I-III;
* Hamilton anxiety scale ≥ 8.

Exclusion Criteria:

* Having serious mental illness before surgery or on antipsychotic medication in the two weeks before screening;
* Severe organ function lesions such as heart failure (left ventricular ejection fraction \<30%), myocardial infarction, kidney failure (requiring kidney replacement therapy), liver function impairment (Child-Pugh grade C), etc.
* Patients arranged to receive general anesthesia combined with epidural anesthesia patients;
* Patients who cannot communicate, read or write due to visual, auditory, language or other reasons;
* Patients allergic to ketamine;
* Patients refused to use postoperative self-controlled intravenous analgesia pump;
* Patients refused to participate in the study.

Study Locations (1)

Zhejiang cancer hospital
Hangzhou, Zhejiang, China

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Effect of Esketamine on Anxiety State in Patients Undergoing Abdominal Tumor Surgery | Huxley